Skip to search formSkip to main contentSkip to account menu

Fenofibrat AZU

Known as: AZU, Fenofibrat 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Fenofibrate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
ANALYSIS OF MARKET DATA REGARDING THE MEDICINES USED IN TREATMENT OF DYSLIPIDAEMIA
Dyslipidaemias are some of the most frequent metabolic diseases encountered in medical practice. Due to the increasing number of… 
2013
2013
Rhabdomyolysis Due to Statine and Fibrate Combination Theraphy: A Single Case
Hidroksi metil glutaril coenzim A redüktaz inhibitörü olan statinler serum total kolesterol ve LDL kolesterol seviyelerini d… 
2011
2011
Fenofibrat Kullanımına Bağlı Bir Rabdomiyoliz Olgusu / Rhabdomyolysis Case Report Caused By Fenofibrate Using
2009
2009
Dislipidemik hastalarda 4 haftalık kısa dönem günde tek doz 200 mg mikronize fenofibrat tedavisinin etkinlik ve güvenilirliği
Suleyman Demirel Universitesi TIP FAKULTESI DERGISI: 2004 Eylul; 11(3) Dislipidemik hastalarda 4 haftalik kisa donem gunde tek… 
2008
2008
[Effect of fenofibrate on fibrinogen concentration and blood viscosity. Consequences for myocardial microcirculation in coronary heart disease?].
The effect of fenofibrate (a clofibrate derivative) on fibrinogen concentration, blood viscosity and myocardial microcirculation… 
2006
2006
Modulation inflammatorischer Atherosklerosemarker durch Peroxisome proliferator-activated receptor-alpha (PPARalpha)-aktivierendes Fenofibrat
2003
2003
Die Auswirkungen von Atorvastatin versus Fenofibrat auf Lipoproteinprofil, LDL-Subtypenverteilung, Entzündungsmarker und hämorheologische Paramter bei Typ-2-Diabetikern mit gemischter…
2001
2001
Porównanie monoterapii fenofibratem z leczeniem skojarzonym: fluwastatyną i fenofibratem w pacjentów z pierwotną hipercholesterolemią
To badanie o charakterze podwojnie ¶lepej proby zaprojektowano, aby oceniae skuteczno¶ae i bezpieczenstwo leczenia skojarzonego… 
1989
1989
Einfluß von Fenofibrat auf Fibrinogenkonzentration und Blutfluidität* 1: Konsequenzen für die myokardiale Mikrozirkulation bei der koronaren Herzerkrankung?
P P P P 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)